loader2
Partner With Us NRI

Bajaj Healthcare Ltd share Price Today

Company details

349.30
358.25
263.30
513.40
6M Return -6.13%
1Y Return 13.12%
Mkt Cap.(Cr) 965.93
Volume 17,757
Div Yield 0.28%
OI
-
OI Chg %
-
Volume 17,757

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Pharmaceuticals firm Bajaj Healthcare announced Q1FY23 Result :

  • Revenue from Operations has marginally degrown by 7.32% from Rs.1,856.89 Mn in Q1 FY22 to Rs.1720.69 Mn in Q1 FY23 mainly due to contraction of Covid-19 led opportunities.
  • EBITDA has degrown by 22.85% from Rs.334.98 Mn in Q1 FY22 to Rs.258.44 Mn in Q1 FY23. There was de-growth in EBIDTA Margins from 18.04% in Q1 FY22 to 15.02% in Q1 FY23 on a YoY basis. The degrowth in EBITDA margins was mainly on account of weakening of Indian Rupee, thereby leading to an increase in imported raw material cost. The EBITDA margins strengthened on a sequential quarter basis by 67bps.
  • Net profit has decline by 37.46% from Rs.192.18 Mn in Q1 FY22 to Rs. 120.19 Mn in Q1 FY23. The Net Profit Margins were at 6.98% in Q1 FY23 from 10.35% in Q1 FY22 owing to a decline in EBITDA margins as explained above.

Commenting on the Q1 FY23 results, Mr. Sajankumar Bajaj (Chairman) said: “We are pleased to inform all our stakeholders that the company has reported an overall stable financial performance in Q1 FY23 despite witnessing inflationary headwinds for the major part of the quarter. Despite declining contribution from Covid related products, The company was able to retain its revenue achieved in Q1FY22 on account of covid related demand and post an improvement in quarterly EBITDA margins on a sequential basis."

Result PDF

View Other Company Results

Bajaj Healthcare Ltd shares SWOT Analysis

Strengths (2)

  • Increasing Revenue every quarter for the past 2 quarters
  • Company with Zero Promoter Pledge

Weakness (9)

  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years
  • Inefficient use of assets to generate profits - ROA declining in the last 2 years

Opportunity (1)

  • Stock with Low PE (PE < = 10)

Threats (1)

  • Increasing Trend in Non-Core Income

Resistance and support

R1 360.2
R2 368.6
R3 377.9
Pivot

350.93

S1 342.5
S2 333.2
S3 324.8
EMA SMA
355.9
337.6
333.1
339.7
358.2
324.8
321.9
352.8
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
GRAVITON RESEARCH CAPITAL LLP Bulk Purchase 2024-07-11 399.93 142829 NSE
GRAVITON RESEARCH CAPITAL LLP Bulk Sell 2024-07-11 400.63 142829 NSE
GRAVITON RESEARCH CAPITAL LLP Bulk Purchase 2024-07-10 396.56 152742 NSE
Name Category Shares
SAJANKUMAR RAMESHWARLAL BAJAJ PROMOTER 35.19%
S K R BAJAJ HUF PROMOTER 7.83%
NAMRATA BAJAJ PROMOTER 5.91%
NIHITA SAJANKUMAR BAJAJ PROMOTER 5.87%
BABITA SAJANKUMAR BAJAJ PROMOTER 5.45%
ANIL CHAMPALAL JAIN PROMOTER 5.3%
PADMA ANIL JAIN PROMOTER 1.1%
BAJAJ HEALTH & NUTRITIONS PRIVATE LIMITED PROMOTER 0.87%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Bajaj Healthcare Ltd Stocks COMPARISON

Financials( in Cr) Bajaj Healthcare Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 350.00 1,591.80 1,490.60 4,509.10 1,146.90
% Change -10.59 -0.42 -1.49 -2.76 -2.82
Mcap Cr 965.93 381,926.15 120,368.63 119,702.63 115,404.98
Revenue TTM Cr 673.29 48,496.85 15,790.60 7,845.00 19,547.40
Net Profit TTM Cr 43.02 9,648.44 2,513.47 1,600.00 3,854.40
PE TTM 33.89 38.13 28.25 75.10 30.09
1 Year Return 13.12 52.33 46.61 23.88 97.20
ROCE 11.82 17.20 14.76 16.41 23.94
ROE 12.36 16.13 10.66 12.15 20.64
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 367.69 Cr FV: 5.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 8,937.56 45,192.41
LAST 3M 92,628.05 55,620.51
LAST 6M 175,219.32 60,530.78
LAST 12M 306,910.23 88,097.76

Bajaj Healthcare Ltd Information

Stock PE (TTM)
33.89
Promoter Holding
67.73%
Book Value
100.8606
ROCE
11.82%
ROE
12.36%
Description
  • Bajaj Healthcare Ltd. is in the business of manufacturing pharmaceutical products and bulk drugs. It is valued at Rs. 917 crore on the stock exchange. The company was incorporated in 1993. The key figures in the company’s management are Mr Pakshal A Jain, Mr Rupesh H Nikam, and Mr Sajan Kumar R Bajaj. Bajaj Healthcare’s net profit was Rs. 17.45 crore in the third quarter of FY 2021-22. The share price of Bajaj Healthcare is traded under the script name of BAJAJHCARE on both the stock exchanges (NSE & BSE). 

    Bajaj Healthcare’s product segment comprises formulations and bulk drugs. Its therapeutic API portfolio includes anticonvulsants, vitamins, bactericidal, bronchodilators, and so on. It offers anti-Platelets, anti-arrhythmia, anti-hypertensive, and a few more in the FDF segment.

    Bajaj Healthcare Ltd.’s price-to-earnings (PE) ratio and price-to-book (PB) ratio are better than its industry average. The PE ratio is 10.89, and the PB ratio is 3.52. For the past five years, the company’s average annual revenue and profit growth rates were 24.36% and 58.88%, respectively. Bajaj Healthcare reported a net income of Rs. 7.80 crore, Rs. 15.20 crore, Rs. 16.30 crore, Rs. 25.25 crore, and Rs. 83.11 crore in the past five financial years. The company declared a dividend of Rs. 1.38 and an EPS of Rs. 30.11. The company’s overall assets have increased significantly over the past two years. However, total liabilities have also increased during the same period. During the past five years, the company’s average debt-to-income ratio and current ratio have been 67.1% and 117.13%, respectively. For the financial year 2021, the company’s financials showed a negative free cash flow.

    On April 6, 2022, Bajaj Healthcare’s share price on BSE closed at Rs. 373.75. Bajaj Healthcare’s share price performance on the price chart was quite satisfying, as it reported an annual return of 64.39% in the past 12 months. The 52-week low of Bajaj Healthcare’s share price was Rs. 213.45. The high for the same period was recorded at Rs. 511.90. Investing in Bajaj Healthcare is extremely risky due to its high volatility of 3.43x the NIFTY. Some of the industries’ key competitors of Bajaj Healthcare on the stock exchange are Cipla Ltd., Gland Pharma Ltd., Sun Pharmaceuticals Industries Ltd., Dr Reddy’s Laboratories Ltd., and Torrent Pharmaceuticals Ltd. 

    Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code :07730), BSE Ltd (Member Code :103) and Member of Multi Commodity Exchange of India Ltd. (Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest.  I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.

Registered Address

602-606 Bhoomi Velocity Infote, Road No 23 Wagle Indl Estate, Thane, Maharashtra, 400604

Tel : 91-22-66177400/401
Email : investors:bajajhealth.com
Website : http://www.bajajhealth.com
Registrar

Sharex Dynamic (India) Pvt Ltd

AGM Date (Month) : Oct
Face Value Equity Shares : 5
Market Lot Equity Shares : 1
BSE Code : 539872
NSE Code : BAJAJHCARE
Book Closure Date (Month) : Sep
BSE Group : B
ISIN : INE411U01027

FAQ’s on Bajaj Healthcare Ltd Shares

You can buy Bajaj Healthcare Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Bajaj Healthcare Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jul 23, 2024 09:39 AM the closing price of Bajaj Healthcare Ltd was Rs.350.00.

The latest PE ratio of Bajaj Healthcare Ltd as of Jul 23, 2024 09:39 AM is 33.89

The latest PB ratio of Bajaj Healthcare Ltd as of Jul 23, 2024 09:39 AM is 0.29

The 52-week high of Bajaj Healthcare Ltd share price is Rs. 513.40 while the 52-week low is Rs. 263.30

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jul 23, 2024 09:39 AM, the market cap of Bajaj Healthcare Ltd stood at Rs. 965.93 Cr.

Download App

Download Our App

Play Store App Store
market app